Jonker, Pascal K. C.
Metman, Madelon J. H.
Sondorp, Luc H. J.
Sywak, Mark S.
Gill, Anthony J.
Jansen, Liesbeth
Links, Thera P.
van Diest, Paul J.
van Ginhoven, Tessa M.
Löwik, Clemens W. G. M.
Nguyen, Anh H.
Coppes, Robert P.
Robinson, Dominic J.
van Dam, Gooitzen M.
van Hemel, Bettien M.
Fehrmann, Rudolf S. N.
Kruijff, Schelto http://orcid.org/0000-0002-5151-7320
Funding for this research was provided by:
KWF Kankerbestrijding (10851)
Article History
Received: 12 December 2021
Accepted: 11 March 2022
First Online: 7 April 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was granted by the Northern Sydney Local Health District Human Research Ethics Committee and the Medical Ethics Committee of the University Medical Center Groningen.
: Informed consent was obtained from all individual participants included in the study.
: GMvD is a member of the scientific board of SurgVision BV, founder, shareholder, and CEO of TRACER Europe BV (Groningen, the Netherlands). None of the other authors reported any potential conflicts of interest.